Dopamine agonist withdrawal syndrome frequency determined prospectively

From Clinical Neurology News, 24 June 2013: Nearly one-quarter of patients decreasing or stopping dopamine agonist therapy experience dopamine agonist withdrawal syndrome, and one third of those suffer severe symptoms, according to results from the EuroDaws study. In the prospective, observational study of 51 patients with Parkinson’s disease who were withdrawn from dopamine agonist treatment, Continue reading Dopamine agonist withdrawal syndrome frequency determined prospectively